LabCompass

Nerea Lopetegui‐Lia

Medicine · The Ohio State University

Early career · publishing since 2019

Publications

71

Citations

371

Est. group size

~2

Recurring co-author estimate

Active years

8

Publishing since 2019

Research summary
AI-generated

Nerea Lopetegui-Lia's research focuses on breast cancer, particularly hormone receptor-positive and triple-negative subtypes, and how factors like BRCA gene mutations, age, and hormone receptor status affect treatment outcomes and survival. The work also examines real-world treatment patterns, socioeconomic barriers to care, and biomarkers that may predict how well patients respond to therapy. This research is largely clinical and population-based, drawing on large patient databases and cohort studies rather than laboratory experiments.

Breast cancer treatment and outcomesBRCA gene mutations in young cancer patientsHormone receptor-positive and HER2 breast cancer subtypesReal-world treatment patterns and healthcare disparitiesBiomarkers for immunotherapy response

Publication output has been variable over the past decade, with an early cluster of activity in 2019-2020, a dip around 2021-2023, and a renewed increase from 2024 through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.0/year recently
17182019: 15 publications15192020: 15 publications15202021: 6 publications212022: 6 publications222023: 7 publications232024: 10 publications242025: 11 publications252026: 1 publication26
Recent publications
Publishes in
  • Journal of Clinical Oncology×13
  • Cureus×9
  • ESMO Open×4
  • The American Journal of Medicine×4
  • Clinical Cancer Research×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile